Literature DB >> 9445207

Laser-induced chorioretinal venous anastomosis for nonischemic central or branch retinal vein occlusion.

S Fekrat1, M F Goldberg, D Finkelstein.   

Abstract

OBJECTIVE: To establish a communication between an obstructed retinal vein and the choroid by means of laser in eyes with nonischemic central or branch vein occlusion.
METHODS: Retrospective review identified eyes with nonischemic central or branch vein occlusion, and with decreasing or persistently decreased visual acuity of 20/100 or worse for 4 months or more before treatment, that received 1 or more sessions of laser photocoagulation to create a chorioretinal anastomosis.
RESULTS: Of 24 eyes with central vein occlusion, an anastomosis formed in 9 (38%) within 2 months after treatment, with visual improvement of 6 or more lines in 2 (8%) of 24 eyes, 1 to 3 lines in 5 (21%), and no improvement in 2 (8%). Of 6 eyes with branch vein occlusion, an anastomosis formed in 3 (50%) within 2 months after treatment, with visual improvement of 1 to 3 lines in 2 (33%) of 6 and no improvement in 1 (16%). No permanent, vision-limiting complications occurred during a mean follow-up of 13 months after the first treatment session or 8 months after the last session.
CONCLUSIONS: Laser photocoagulation of a retinal vein and Bruch's membrane may create a chorioretinal anastomosis in some eyes with a nonischemic vein occlusion. Progression to an ischemic status may possibly be prevented with successful anastomosis formation. Marked visual improvement may occur. Treatment techniques to create reliably an anastomosis with subsequent visual improvement, while minimizing potential complications, continue to evolve.

Entities:  

Mesh:

Year:  1998        PMID: 9445207     DOI: 10.1001/archopht.116.1.43

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  13 in total

Review 1.  The management of retinal vein occlusion: is interventional ophthalmology the way forward?

Authors:  H Shahid; P Hossain; W M Amoaku
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

2.  Laser induced chorioretinal venous anastomosis in ischaemic central retinal vein occlusion.

Authors:  A K H Kwok; V Y W Lee; T Y Y Lai; C Hon
Journal:  Br J Ophthalmol       Date:  2003-08       Impact factor: 4.638

3.  Surgical induction of chorioretinal venous anastomosis in ischaemic central retinal vein occlusion: a non-randomised controlled clinical trial.

Authors:  A Mirshahi; R Roohipoor; A Lashay; S F Mohammadi; M R Mansouri
Journal:  Br J Ophthalmol       Date:  2005-01       Impact factor: 4.638

4.  One-year results after intravitreal bevacizumab therapy for macular edema secondary to branch retinal vein occlusion.

Authors:  Gesine B Jaissle; Martin Leitritz; Faik Gelisken; Focke Ziemssen; Karl Ulrich Bartz-Schmidt; Peter Szurman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-08-12       Impact factor: 3.117

Review 5.  [Bevacizumab for treatment of macular edema secondary to retinal vein occlusion].

Authors:  G B Jaissle; F Ziemssen; K Petermeier; P Szurman; M Ladewig; F Gelisken; M Völker; F G Holz; K U Bartz-Schmidt
Journal:  Ophthalmologe       Date:  2006-06       Impact factor: 1.059

6.  Intravitreous bevacizumab in the treatment of macular edema from branch retinal vein occlusion and hemisphere retinal vein occlusion (an AOS thesis).

Authors:  Gary Edd Fish
Journal:  Trans Am Ophthalmol Soc       Date:  2008

7.  Combined intravitreal triamcinolone injection and laser photocoagulation in eyes with persistent macular edema after branch retinal vein occlusion.

Authors:  Juliane Riese; Vlassis Loukopoulos; Cornelia Meier; Melanie Timmermann; Heinrich Gerding
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-08-16       Impact factor: 3.117

8.  A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6.

Authors:  Ingrid U Scott; Michael S Ip; Paul C VanVeldhuisen; Neal L Oden; Barbara A Blodi; Marian Fisher; Clement K Chan; Victor H Gonzalez; Lawrence J Singerman; Michael Tolentino
Journal:  Arch Ophthalmol       Date:  2009-09

9.  In vivo retinal vascular cannulation in rabbits.

Authors:  Yukihiko Suzuki; Hideaki Matsuhashi; Mitsuru Nakazawa
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-06-18       Impact factor: 3.117

10.  Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion.

Authors:  Gesine B Jaissle; Peter Szurman; Nicolas Feltgen; Bernhard Spitzer; Amelie Pielen; Matus Rehak; Georg Spital; Heinrich Heimann; Carsten H Meyer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-08-18       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.